Dr. Preusting is currently CEO of Synerkine Pharma and has previously served as the Chief Business Officer of uniQure. He was previously the Director of Process Development and Manufacturing at AMT, the predecessor of uniQure. Dr. Preusting also works as an independent consultant to several biotech companies.
Dr. Preusting holds two patents and has published over 20 scientific articles. His expertise is focused in business development, product development and manufacturing using fermentation and cell culture techniques. He earned a Ph.D. in biochemistry and an M.B.A. from the Rotterdam School of Management.